Trialect

Verified

NOIP: NIH Research Evaluation and Commercialization Hubs (REACH)

National Institutes of Health

Note: This is a Forecasted Opportunity.

The National Institutes of Health (NIH), including all of its Institutes and Centers, plans to publish a Notice of Funding Opportunity inviting eligible colleges, universities, and nonprofit organizations to apply for the NIH Research Evaluation and Commercialization Hub (REACH) program. The REACH program helps move promising biomedical discoveries from academic research into real-world products that can improve patient care and public health. Through this opportunity, NIH plans to fund five new academic entrepreneurship hubs. These hubs will support researchers by providing early-stage funding, technical and business resources, and mentorship in product development and commercialization. The hubs will focus on high-priority technologies that align with NIH's mission. Together, the funded hubs will form a technology development consortium that will help:

Identify the most promising academic biomedical technologies;
Fund early product-development work, such as feasibility studies, prototypes, and proof-of-concept studies;
Provide access to expertise in science, regulation, reimbursement, business, law, and project management; and
Offer entrepreneurship training and hands-on commercialization experience.

Public-private partnerships and non-federal matching funding will be important to the program's success. The five awardees will build on lessons learned from previous REACH hubs and support the goals of the Phase 0 Proof of Concept Partnership pilot program, as authorized by the 2011 SBIR/STTR Reauthorization Act (P.L. 112-81 Section 5127) and extended through fiscal year 2031 under the Small Business Innovation and Economic Security Act (P.L. 119-83). The REACH program also supports federal research and development priorities, including preparing the 21st-century workforce, moving technologies from the lab to the marketplace, strengthening partnerships among government, industry, and academia, and addressing local health needs, particularly in medically underserved and/or rural areas.

Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.

Estimated Post Date:

Sep 30, 2026

Estimated Application Due Date:

Nov 30, 2026

Specialties

Medical

Medical - Clinical Science

Medical - Basic Science

Medical - Translational

Eligibility Requirements

Sponsor Details

Sponsor Institute/Organizations: National Institutes of Health

Sponsor Type: Government/Federal

Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity